Living With Limitations in the Family

This is the misunderstood side of my life - how I live with limitations. The other day, I visited my mother who also has RA. We went for a walk. I don't usually go for walks because I get plenty of exercise at the gym and going for walks isn't a great exercise for me. My back hurts and I get tired.Other family members insist my mother go for walks too. They give her directions like if she would walk further she can get in better shape. She also should do her exercises, which she does. And she rides her little stationary bike while watching the news for 30 minutes every night. She gets plenty of exercise and really can't do more. I go to the gym three times a week and that's plenty of exercise for me.My mother has had RA since 1989 and I have had it since 2012 (I think, maybe 2013). In addition we both have bad backs. She has had numerous back surgeries. I have just had cancer a couple of times.With our health, we are not interested in getting healthier by working out because we are more interested in maintaining their health than becoming body builders. We just don't want to do too much and exhaust ourselves and then need days to recover and feel better.We went for a walk. My mother had her rollator (brand is Hugo - She calls it Hugo, I call it Victor). We started our walk. We went down hill (because the hill is steeper if we go uphill) and we decided we would go until we felt we had walked enough and then would turn around. We went past the neighbors across the street, and t...
Source: Caroline's Breast Cancer Blog - Category: Cancer & Oncology Tags: limitations vacation walking Source Type: blogs

Related Links:

Cowden syndrome (CS) is a multiple hamartoma syndrome associated with the development of various tumors, including endometrial cancer. However, the histology of CS-associated endometrial cancer remains to be fully described. To our knowledge, this is the first report of a patient with CS having endometrial endometrioid carcinoma with ovarian metastasis demonstrating morula-like features. A 31-yr-old, nulliparous, Japanese woman presented with abnormal genital bleeding. Endometrial biopsy revealed endometrioid carcinoma with an extensive morular formation, partially resembling atypical polypoid adenomyoma (APAM). Moreover, ...
Source: International Journal of Gynecological Pathology - Category: Pathology Tags: PATHOLOGY OF THE CORPUS: CASE REPORT Source Type: research
PET/MRI is better than MRI alone for the detection and staging of nodes and...Read more on AuntMinnie.comRelated Reading: Can FDG-PET/MRI replace biopsy in breast cancer cases? PET/MRI sheds light on cerebral vascular risk factors PET/MRI can pinpoint causes of chronic extremity pain SNMMI: FDG-PET/MRI improves pain diagnosis, management PET/MRI offers view to atherosclerotic disease origin
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
             Basel, 13 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the Phase III IMspire150 study, in people with previously untreated BRAF V600 mutation-positive advanced melanoma, met its primary endpoint of progression-free survival (PFS). The study showed adding Tecentriq ® (atezolizumab) to Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) helped to reduce the risk of disease worsening or death, compared to placebo plus Cotellic and Zelboraf. A significant and clinically meaningful improvement in PFS was demonstrated in the study. The safety ...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Source Type: research
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
A current phase 3 trial showed that partial breast irradiation — as opposed to irradiating the whole breast — could be a viable alternative in patients with early, low-risk breast cancer.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Analyst, 2020, Advance Article DOI: 10.1039/C9AN01830A, PaperRenhui Zhan, Xiaofeng Li, Lixin Zang, Kehua Xu A nanoprobe based on high-fidelity Au –Se bonds was developed for the imaging and real-time monitoring of the sequential activation of uPA and MMP-2 and its application to evaluate the invasive potential of breast cancer cells. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Analyst latest articles - Category: Chemistry Authors: Source Type: research
Trastuzumab emtansine showed no disease-free survival or safety advantage over paclitaxel + trastuzumab in the adjuvant setting for patients with stage 1 HER2-positive breast cancer.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Blogging | Breast Cancer | Cancer | Cancer & Oncology | Sports Medicine